Home » Newsletters » BioWorld Science

BioWorld Science

March 14, 2019

View Archived Issues

Identification of a novel target for the development of stroke treatments

Hitgen, Sun Pharma Advanced Research enter DEL-based drug discovery collaboration

Gene editing alleviates AD deficits in mouse models

China's NMPA clears HDAC6 inhibitor CS-3003 for phase I trials

Runx2 as a new target in chronic rhinosinusitis with neo-osteogenesis

AAV delivery of EPO-R76E delays retinal degeneration in a mouse model of geographic atrophy

Discovery of the first selective inhibitor of group XVI phospholipase A2

ACAM is a potential molecular target for treating multiple sclerosis

Identification of pyrrolidine amide derivatives as novel N-acylethanolamine acid amidase inhibitors

Results on safety, tolerability and pharmacokinetics of benapenem in healthy volunteers

Discovery of a druggable mechanism underlying tumorigenesis in ovarian cancer

RGC-32 as new target in chronic multiple sclerosis

Apelin receptor agonists identified at Bristol-Myers Squibb

Amgen presents new Mcl-1 inhibitors

Identification of a biomarker of inflammatory bowel disease severity

Wee1-like protein kinase inhibitors patented by Shanghai De Novo Pharmatech

Selection Bioscience discloses androgen receptor antagonists

Development of a novel, selective, kappa-opioid receptor antagonist

JS Innopharm patents ERK-2 inhibitors

AbbVie initiates phase I study of alpha-synuclein-targeting antibody ABBV-0805 for Parkinson's

Kyowa Hakko Kirin begins phase I study of KHK-4323 for atopic dermatitis

LRP-1 targeting confers retinal neuroprotection in diabetic mice

Phase III VELOS-2 trial explores use of HL-036 in patients with dry eye

BrainStorm initiates phase II study of MSC-NTF cells in progressive MS

Biohaven initiates phase III trial of troriluzole for spinocerebellar ataxia

Infinity and Roche enter master clinical supply agreement for MARIO-3 combination trial of IPI-549

Popular Stories

23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Today's news in brief
BioWorld
BioWorld briefs for June 17, 2025.
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 17, 2025.
EACR 2025: Immune rewiring in cancer orchestrates tumor microenvironment
BioWorld Science
Among the presentations included in the Top Abstracts category at the recently inaugurated Annual Congress of the European Association for Cancer Research (EACR)...